These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
998 related items for PubMed ID: 2949018
21. Characterization of the CD4+ and CD8+ tumor infiltrating lymphocytes propagated with bispecific monoclonal antibodies. Wong JT, Pinto CE, Gifford JD, Kurnick JT, Kradin RL. J Immunol; 1989 Nov 15; 143(10):3404-11. PubMed ID: 2509557 [Abstract] [Full Text] [Related]
22. Antigenic, functional, and molecular genetic studies of human natural killer cells and cytotoxic T lymphocytes not restricted by the major histocompatibility complex. Lanier LL, Le AM, Cwirla S, Federspiel N, Phillips JH. Fed Proc; 1986 Nov 15; 45(12):2823-8. PubMed ID: 3095151 [Abstract] [Full Text] [Related]
23. CD3-negative lymphokine-activated cytotoxic cells express the CD3 epsilon gene. Biassoni R, Ferrini S, Prigione I, Moretta A, Long EO. J Immunol; 1988 Mar 01; 140(5):1685-9. PubMed ID: 2894394 [Abstract] [Full Text] [Related]
24. CD45-mediated regulation of LFA1 function in human natural killer cells. Anti-CD45 monoclonal antibodies inhibit the calcium mobilization induced via LFA1 molecules. Poggi A, Pardi R, Pella N, Morelli L, Sivori S, Vitale M, Revello V, Moretta A, Moretta L. Eur J Immunol; 1993 Oct 01; 23(10):2454-63. PubMed ID: 8405045 [Abstract] [Full Text] [Related]
25. The human natural killer cell receptor for major histocompatibility complex class I molecules. Surface modulation of p58 molecules and their linkage to CD3 zeta chain, Fc epsilon RI gamma chain and the p56lck kinase. Bottino C, Vitale M, Olcese L, Sivori S, Morelli L, Augugliaro R, Ciccone E, Moretta L, Moretta A. Eur J Immunol; 1994 Oct 01; 24(10):2527-34. PubMed ID: 7523145 [Abstract] [Full Text] [Related]
26. A subset of CD16-natural killer cells without antibody-dependent cellular cytotoxicity function. Schubert J, Heiken H, Jacobs R, Delany P, Witte T, Schmidt RE. Nat Immun Cell Growth Regul; 1990 Oct 01; 9(2):103-11. PubMed ID: 2141105 [Abstract] [Full Text] [Related]
27. Alloantigen-specific cytotoxic clones bearing the alpha,beta T cell antigen receptor but not CD4 or CD8 molecules. Rivas A, Koide J, Laus R, Engleman EG. J Immunol; 1990 Jul 15; 145(2):470-6. PubMed ID: 2142178 [Abstract] [Full Text] [Related]
28. Lymphokine-activated killer activity in long-term cultures with anti-CD3 plus interleukin 2: identification and isolation of effector subsets. Ochoa AC, Hasz DE, Rezonzew R, Anderson PM, Bach FH. Cancer Res; 1989 Feb 15; 49(4):963-8. PubMed ID: 2521457 [Abstract] [Full Text] [Related]
29. Evidence for involvement of the gamma, delta T cell antigen receptor in cytotoxicity mediated by human alloantigen-specific T cell clones. Rivas A, Koide J, Cleary ML, Engleman EG. J Immunol; 1989 Mar 15; 142(6):1840-6. PubMed ID: 2466078 [Abstract] [Full Text] [Related]
30. NK 1+ CD4- CD8- alphabeta T cells in the peritoneal cavity: specific T cell receptor-mediated cytotoxicity and selective IFN-gamma production against B cell leukemia and myeloma cells. Sugie T, Kubota H, Sato M, Nakamura E, Imamura M, Minato N. J Immunol; 1996 Nov 01; 157(9):3925-35. PubMed ID: 8892624 [Abstract] [Full Text] [Related]
31. Cord blood CD16+56- cells with low lytic activity are possible precursors of mature natural killer cells. Gaddy J, Broxmeyer HE. Cell Immunol; 1997 Sep 15; 180(2):132-42. PubMed ID: 9341743 [Abstract] [Full Text] [Related]
32. Tyrosine kinase-dependent activation of human NK cell functions upon stimulation through a 58-kDa surface antigen selectively expressed on discrete subsets of NK cells and T lymphocytes. Melero I, Salmerón A, Balboa MA, Aramburu J, López-Botet M. J Immunol; 1994 Feb 15; 152(4):1662-73. PubMed ID: 8120376 [Abstract] [Full Text] [Related]
33. Antigen specific and MHC nonrestricted cytotoxicity of T cell receptor alpha beta+ and gamma delta+ human T cell clones isolated in IL-4. Paliard X, Yssel H, Blanchard D, Waitz JA, deVries JE, Spits H. J Immunol; 1989 Jul 15; 143(2):452-7. PubMed ID: 2472439 [Abstract] [Full Text] [Related]
34. A novel surface molecule expressed by long-term cultured T and natural killer cells is involved in cell activation. Ferrini S, Cantoni C, Ciccone E, Biassoni R, Prigione I, Bottino C, Venzano P, Moretta L. Eur J Immunol; 1991 Sep 15; 21(9):1981-7. PubMed ID: 1832383 [Abstract] [Full Text] [Related]
35. A novel functional cell surface dimer (Kp43) expressed by natural killer cells and gamma/delta TCR+ T lymphocytes. II. Modulation of natural killer cytotoxicity by anti-Kp43 monoclonal antibody. Aramburu J, Balboa MA, Izquierdo M, López-Botet M. J Immunol; 1991 Jul 15; 147(2):714-21. PubMed ID: 1830071 [Abstract] [Full Text] [Related]
36. Human K/natural killer cells targeted with hetero-cross-linked antibodies specifically lyse tumor cells in vitro and prevent tumor growth in vivo. Titus JA, Perez P, Kaubisch A, Garrido MA, Segal DM. J Immunol; 1987 Nov 01; 139(9):3153-8. PubMed ID: 2959724 [Abstract] [Full Text] [Related]
37. Anti-CD3 and phorbol myristate acetate regulation of MHC unrestricted T cell cytotoxicity. Lack of a requirement for CD3/T cell receptor complex expression during tumor cell lysis. Thiele DL, Patel SS, Lipsky PE. J Immunol; 1988 May 01; 140(9):3253-60. PubMed ID: 2966209 [Abstract] [Full Text] [Related]
38. Analysis of the functional capabilities of CD3+CD4-CD8- and CD3+CD4+CD8+ human T cell clones. Patel SS, Wacholtz MC, Duby AD, Thiele DL, Lipsky PE. J Immunol; 1989 Aug 15; 143(4):1108-17. PubMed ID: 2526180 [Abstract] [Full Text] [Related]
39. Mechanisms of lysis by cytotoxic T lymphocyte clones. Lytic activity and gene expression in cloned antigen-specific CD4+ and CD8+ T lymphocytes. Lancki DW, Hsieh CS, Fitch FW. J Immunol; 1991 May 01; 146(9):3242-9. PubMed ID: 1673149 [Abstract] [Full Text] [Related]
40. Normal hematopoietic progenitor cells and malignant lymphohematopoietic cells show different susceptibility to direct cell-mediated MHC-non-restricted lysis by T cell receptor-/CD3-, T cell receptor gamma delta+/CD3+ and T cell receptor-alpha beta+/CD3+ lymphocytes. Voogt PJ, Falkenburg JH, Fibbe WE, Veenhof WF, Hamilton M, Van Krimpen BA, Bolhuis RL. J Immunol; 1989 Mar 01; 142(5):1774-80. PubMed ID: 2521886 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]